- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Nanopoint, Inc. has announced its strong network of Asian distributors who include DayMoon Industries of Korea;, DI Biotech LTD of Korea; JC Biotech of Korea; JK Bio of Delhi, India; Joagene BioScience of Korea, Quantum Design China of China; Quantum Design Japan of Japan; and Trade 21 Pte., LTD of Singapore and SinWan Biotech LTD of Taiwan.
Nanopoint Inc., an award-winning developer of cellTRAY® Fluidics and Imaging System products, is announcing the strong network of Asian distributorships the Company is building in order to provide the best-of-the-best customer sales and service in the expanding life science markets throughout the Far East. Nanopoint's carefully selected distributors in Korea, India, China, Japan, Singapore and Taiwan will bring their valuable understanding of Asia's diverse commercial cultures and help to expand the end-user base of the Company's total range of cellTRAY products. Nanopoint's level of precision for studying live cells is not available in any other commercially available live cell imaging system. The Asian distributors announced to-date include DayMoon Industries of Korea;, DI Biotech LTD of Korea; JC Biotech of Korea; JK Bio of Delhi, India; Joagene BioScience of Korea, Quantum Design China of China; Quantum Design Japan of Japan; and Trade 21 Pte., LTD of Singapore and SinWan Biotech LTD of Taiwan.
"We are honored that Nanopoint has contracted with such an outstanding group of distributors to represent us in Asia. In today's global marketplace, it's vitally important for us to have representatives on-the-ground who understand and respect the business culture of our clients and who deeply understand the technical specifications and benefits of our cellTRAY family of products," said Cathy Owen, Nanopoint's CEO. "Nanopoint is building a global brand; our headquarters in Hawaii provides a strong geographic base for building strategic market share in Asia as well as in the West--including the Americas and Europe."
Nanopoint is building a global brand; our headquarters in Hawaii provides a strong geographic base for building strategic market share in Asia as well as in the West--including the Americas and Europe.
In June 2008, Nanopoint will formally launch its cellTRAY® Imaging System Model CT-2000 and make its cellTRAY Fluidics System Model CT-2000F commercially available for purchase. Nanopoint's cellTRAY® Imaging System Model CT-2000 adds in all the precision navigation and image acquisition capabilities for drug screening and targeted nanoparticle delivery applications. The Model CT-2000 offers the most advanced, on-microscope, environmental control system available. The system allows experiments to run on an inverted microscope for extended periods of time, enabling time-lapse imaging of live cells over the course of several days.
Nanopoint's cellTRAYs have been carefully designed to enable scientists to easily move from a Petri dish or microtiter plate style of research to a more precise live cell imaging system. Each of the products has been designed to allow a methodical migration to a miniaturized research platform starting with the cellTRAY, a microscope slide-sized high precision etched well device that can be used with any laboratory equipment supporting slides, to the cellTRAY Imaging System Model CT-1000 which is an add-on to an upright or inverted microscope, to the cellTRAY Fluidics System Model CT-2000F and the cellTRAY Imaging System Model CT-2000 which can be easily added to an inverted microscope. Nanopoint's proprietary software provides the navigation, camera, shutter and filter controls, auto-focus, and microfluidics control necessary for today's demanding live cell imaging applications.
About Nanopoint, Inc.
Nanopoint, Inc. is a privately-held nano-biotechnology company that is revolutionizing the study and treatment of diseases with its live cell imaging solutions. Nanopoint's cellTRAY Fluidics and Imaging System products have broad applications to life science research, drug discovery, and biopharmaceutical production as well as other areas where live cell analysis is important.
For more information, please click here
Sandra Kay Helsel, Ph.D.
SK Helsel & Associates
Copyright © PRWeb™If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015
Dyesol Joins Solliance as an Industrial Partner June 17th, 2015